Friday, June 3, 2022

Promising compound kills range of hard-to-treat cancers by targeting a previously undiscovered vulnerability

A compound called ERX-41 targets a previously unrecognized vulnerability in difficult-to-treat types of cancer including triple-negative breast cancer. The compound will be studied as a drug for clinical translation.

from Latest Science News -- ScienceDaily https://ift.tt/us3NwyM
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A protein older than blood circulation could transform cancer immunotherapy

A protein that evolved long before the human circulatory system may help unlock stronger cancer treatments. When C3 is produced inside tumor...